Literature DB >> 5362858

Observations on two new adenovirus serotypes with unusual antigenic characteristics.

N R Blacklow, M D Hoggan, J B Austin, W P Rowe.   

Abstract

Mesh:

Substances:

Year:  1969        PMID: 5362858     DOI: 10.1093/oxfordjournals.aje.a121095

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


× No keyword cloud information.
  8 in total

1.  Serologically atypical adenovirus strains of subgenus D are different in their genome from the respective prototypes.

Authors:  T Adrian; B Best; R Wigand
Journal:  Med Microbiol Immunol       Date:  1987       Impact factor: 3.402

Review 2.  Persistent infection by adenoviruses.

Authors:  H G Pereira
Journal:  J Clin Pathol Suppl (R Coll Pathol)       Date:  1972

Review 3.  Infectious diseases: annual review of significant publications.

Authors:  H A Reimann
Journal:  Postgrad Med J       Date:  1971-06       Impact factor: 2.401

4.  Transforming region of group A, B, and C adenoviruses: DNA homology studies with twenty-nine human adenovirus serotypes.

Authors:  J K Mackey; W S Wold; P Rigden; M Green
Journal:  J Virol       Date:  1979-03       Impact factor: 5.103

5.  Immunological relationship among human adenoviruses of subgenus D.

Authors:  R Wigand; D Keller; I Werling
Journal:  Arch Virol       Date:  1982       Impact factor: 2.574

6.  Antigenically intermediate human adenovirus strain associated with conjunctivitis.

Authors:  J C Hierholzer; F H Rodriguez
Journal:  J Clin Microbiol       Date:  1981-02       Impact factor: 5.948

7.  Reference equine antisera to 33 human adenovirus types: homologous and heterologous titers.

Authors:  J C Hierholzer; W C Gamble; W R Dowdle
Journal:  J Clin Microbiol       Date:  1975-01       Impact factor: 5.948

8.  Antigenic relationships among the 47 human adenoviruses determined in reference horse antisera.

Authors:  J C Hierholzer; Y O Stone; J R Broderson
Journal:  Arch Virol       Date:  1991       Impact factor: 2.574

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.